Close monitoring of patients receiving NMBs is important for several reasons:

  • To assess the depth and duration of neuromuscular blockade, which can vary from patient to patient
  • To help determine when additional doses are needed
  • To assess recovery from the block
  • To prevent overdose

Monitoring With Train-of-Four

Monitoring a patient’s responses to a series of four peripheral-nerve stimuli (“train-of-four”) can help you assess the degree of neuromuscular blockade.

Train-of-Four Responses
NIMBEX 200 mg/20 mL bottle

© 2022 AbbVie. All rights reserved.
ULTANE® and its design are registered trademarks of AbbVie Inc.
NIMBEX® and its design are trademarks of GlaxoSmithKline LLC, used under license by AbbVie Inc.
US-NIMB-220002 November 2022

AbbVie logo